Quantitative Sequencing Analysis of the Striatal Transcriptome in a Mouse Model of Alzheimer Disease
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to analyze the transcriptomic changes in the striatum of amyloid precursor protein/ presenilin 1 (APP/PS1) transgenic mice and uncover its association with the methyl-CpG binding protein 2 (MeCP2) mediated-changes in striatal epigenetic signature during Alzheimer disease (AD) pathological progression. Methods: To observe transcriptomic alterations in the striatum before the onset of cognitive impairment in APP/PS1 mice, quantitative 3’mRNA sequencing was performed with RNA extracted from the striatum of 6-month-old and 12-month-old wildtype and APP/PS1 mice. In addition, chromatin immunoprecipitation sequencing was conducted with the DNA from wildtype and APP/PS1 mice of the same age as aforementioned. For transcriptomic analysis, comparison terms were constructed based on aging and transgene expression—normal-aging (12-month-old wildtype/6-month-old wildtype), early-AD (6-month-old APP/PS1/6-month-old wildtype), and late-AD (12-month-old APP/PS1/6-month-old wildtype). To compare the changes in biological pathways and networks, we analyzed gene lists from each comparison term via bioinformatics tools including DAVID (Database for Annotation, Visualization, and Integrated Discovery), STRING (Search Tool for the Retrieval of Interacting Genes/Proteins), and SynGO (Synaptic Gene Ontologies). Furthermore, to assume the effect MeCP2 in AD pathological conditions may have on the transcriptome regulation, analysis of the common genes from Quant-Seq and MeCP2-ChIP-Seq was performed. Results: Enriched pathways including immune system and inflammatory response were confirmed in normal- aging and lateAD, respectively. In particular, enriched pathways of gene expression regulation, transcriptional regulation, and protein catabolic pathways were found to be significantly altered in early-AD. MeCP2-bound genes that were significantly altered in the transcriptome were suggested to be target genes that have a role in the striatum of the early-stage AD model. Conclusions: This study confirmed that the alteration of the striatal transcriptomic profile in APP/PS1 mice was involved with several biological pathways. Additionally, comparative analysis of the transcriptomic changes and the MeCP2 bound regions found that a group of differentially expressed genes may be regulated under the epigenetic control of MeCP2.
Abstract
Purpose: The purpose of this study was to analyze the transcriptomic changes in the striatum of amyloid precursor protein/ presenilin 1 (APP/PS1) transgenic mice and uncover its association with the methyl-CpG binding protein 2 (MeCP2) mediated-changes in striatal epigenetic signature during Alzheimer disease (AD) pathological progression. Methods: To observe transcriptomic alterations in the striatum before the onset of cognitive impairment in APP/PS1 mice, quantitative 3’mRNA sequencing was performed with RNA extracted from the striatum of 6-month-old and 12-month-old wildtype and APP/PS1 mice. In addition, chromatin immunoprecipitation sequencing was conducted with the DNA from wildtype and APP/PS1 mice of the same age as aforementioned. For transcriptomic analysis, comparison terms were constructed based on aging and transgene expression—normal-aging (12-month-old wildtype/6-month-old wildtype), early-AD (6-month-old APP/PS1/6-month-old wildtype), and late-AD (12-month-old APP/PS1/6-month-old wildtype). To compare the changes in biological pathways and networks, we analyzed gene lists from each comparison term via bioinformatics tools including DAVID (Database for Annotation, Visualization, and Integrated Discovery), STRING (Search Tool for the Retrieval of Interacting Genes/Proteins), and SynGO (Synaptic Gene Ontologies). Furthermore, to assume the effect MeCP2 in AD pathological conditions may have on the transcriptome regulation, analysis of the common genes from Quant-Seq and MeCP2-ChIP-Seq was performed. Results: Enriched pathways including immune system and inflammatory response were confirmed in normal- aging and lateAD, respectively. In particular, enriched pathways of gene expression regulation, transcriptional regulation, and protein catabolic pathways were found to be significantly altered in early-AD. MeCP2-bound genes that were significantly altered in the transcriptome were suggested to be target genes that have a role in the striatum of the early-stage AD model. Conclusions: This study confirmed that the alteration of the striatal transcriptomic profile in APP/PS1 mice was involved with several biological pathways. Additionally, comparative analysis of the transcriptomic changes and the MeCP2 bound regions found that a group of differentially expressed genes may be regulated under the epigenetic control of MeCP2.
참고문헌 (25)
- Ding Z, "Exploring the secrets of brain transcriptional regulation: developing methodologies, recent significant findings, and perspectives", Brain Struct Funct, 226, pp.313~322 (2021)
- Chen XF, "Transcriptional regulation and its misregulation in Alzheimer’s disease", Mol Brain, 6, pp.44~ (2013)
- Mutz KO, "Transcriptome analysis using next-generation sequencing", Curr Opin Biotechnol, 24, pp.22~30 (2013)
- Corley SM, "QuantSeq. 3’ Sequencing combined with Salmon provides a fast, reliable approach for high throughput RNA expression analysis", Sci Rep, 9, pp.18895~ (2019)
- Jones PL, "Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription", Nat Genet, 19, pp.187~191 (1998)
- Guy J, "The role of MeCP2 in the brain", Annu Rev Cell Dev Biol, 27, pp.631~652 (2011)
- Chahrour M, "MeCP2, a key contributor to neurological disease, activates and represses transcription", Science, 320, pp.1224~1229 (2008)
- Park PJ, "ChIP–seq : advantages and challenges of a maturing technology", Nat Rev Genet, 10, pp.669~680 (2009)
- Lee S, "Dysfunction of striatal MeCP2 is associated with cognitive decline in a mouse model of Alzheimer’s disease", Theranostics, 12, pp.1404~1418 (2022)
- Kanehisa M, "KEGG : kyoto encyclopedia of genes and genomes", Nucleic Acids Res, 28, pp.27~30 (2000)
- Huang da W, "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources", Nat Protoc, 4, pp.44~57 (2009)
- Snel B, "STRING : a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene", Nucleic Acids Res, 28, pp.3442~3444 (2000)
- Koopmans F, "SynGO: an evidence-based, expert-curated knowledge base for the synapse", Neuron, 103, pp.217~234.e4 (2019)
- 서정선, "Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy", Experimental and Molecular Medicine, 49, pp.1~12 (2017), 생화학분자생물학회
- Feng J, "Identifying ChIP-seq enrichment using MACS", Nat Protoc, 7, pp.1728~1740 (2012)
- Robinson MD, "edgeR : a Bioconductor package for differential expression analysis of digital gene expression data", Bioinformatics, 26, pp.139~140 (2010)
- Liang Z, "Impact of aging immune system on neurodegeneration and potential immunotherapies", Prog Neurobiol, 157, pp.2~28 (2017)
- Streit WJ, "The brain’s aging immune system", Aging Dis, 1, pp.254~261 (2010)
- Sydow A, "Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching offthe toxic Tau mutant", J Neurosci, 31, pp.2511~2525 (2011)
- Leal MC, "Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid β(Aβ)peptide catabolism and functionality", J Biolo Chem, 288, pp.12920~12931 (2013)
- Chen CM, "Wnt5a is essential for hippocampal dendritic maintenance and spatial learning and memory in adult mice", Proc Natl Acad Sci U S A, 114, pp.E619~E628 (2017)
- Rosi MC, "Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease", J Neurochem, 112, pp.1539~1551 (2010)
- Caricasole A, "Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer’s brain", J Neurosci, 24, pp.6021~6027 (2004)
- Li B, "WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity", PLoS One, 6, pp.e22920~ (2011)
- Cerpa W, "Wnt-5aoccludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons", Mol Neurodegener, 5, pp.3~ (2010)